Construction of MPEG-PCL Nanomicelle Ocular Drug Delivery Vector and Its Application in the Treatment of Hypertensive Fundus Disease

Table 3

Anxiety data analysis table.

	Control group	Test group	Time ()	Significant difference (P)
0 day	17.000	17.000	0.074	0.984
1-2 days	15.521	15.387	0.241	0.821
3-4 days	14.127	13.124	1.121	0.234
5-6 days	12.682	11.486	2.012	0.112
7-8 days	11.020	9.264	2.982	0.004
9-10 days	8.869	7.132	3.125	0.003
11-12 days	6.852	4.162	3.632	0.002
13-14 days	3.326	1.521	4.437	0.001